Diabetes and Myocardial Fibrosis
Dante Salvador(University Hospital of Bern), Arjola Bano(University of Bern), Valentina González-Jaramillo(Institute of Social and Preventive Medicine), Beatrice Minder(University of Bern), Christoph Gräni(University of Bern), Taulant Muka(Institute of Social and Preventive Medicine), Oscar H. Franco, Nathalia González-Jaramillo(University of Bern), Magda Gamba(University of Bern), Christoph Stettler(University of Bern), Peter Francis Raguindin(Institute of Social and Preventive Medicine), Matthias Wilhelm(University Hospital of Bern), Alessandro Doria(Joslin Diabetes Center)
Cited by 67
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
|The Lancet|2007|1.4k
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
|European Journal of Preventive Cardiology|2020|924
Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis
|Journal of the American College of Cardiology|2017|426